BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
sun pharma adv.res.co.ltd stock

SUN PHARMA ADV.RES.CO.LTD Share Price

211.97 -3.25 (-1.51%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: SPARC

SUN PHARMA ADV.RES.CO.LTD Share Price Update

As of the latest trading session, SUN PHARMA ADV.RES.CO.LTD share price is currently at 211.97, which is down by -3.25 from its previous closing. Today, the stock has fluctuated between 208.76 and 215.23. Over the past year, SUN PHARMA ADV.RES.CO.LTD has achieved a return of -19.26 %. In the last month alone, the return has been 4.80 %. Read More...

SUN PHARMA ADV.RES.CO.LTD Performance

Day Range

Low208.76 High215.23
211.97

52 Week Range

Low 189.75 High 472.80
211.97

SUN PHARMA ADV.RES.CO.LTD Share Price

14788

532872

SPARC

img img img img
No Data Available

Open Price

215.00

Prev. Close

215.23

Volume (Shares)

284610.00

Total traded value

603.28

Upper Circuit

258.27

Lower Circuit

172.18

Note: The current prices & values are delayed, Login to your account for live updates.

SUN PHARMA ADV.RES.CO.LTD Fundamentals


(Standalone)

Market Cap (Cr) 6878.88
PE Ratio (TTM) -16.75
Book Value / Share 3.84
Beta 1.01
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -107.69

SUN PHARMA ADV.RES.CO.LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 12.86
Operating Expense 120.59
Net Profit -107.69
Net Profit Margin (%) -837.40
Earnings Per Share (EPS) -3.32
EBITDA -103.81
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 16.81
Operating Expense 115.21
Net Profit -96.84
Net Profit Margin (%) -576.08
Earnings Per Share (EPS) -2.98
EBITDA -93.56
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 16.56
Operating Expense 127.64
Net Profit -106.69
Net Profit Margin (%) -644.26
Earnings Per Share (EPS) -3.29
EBITDA -103.12
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 13.86
Operating Expense 119.90
Net Profit -99.65
Net Profit Margin (%) -718.97
Earnings Per Share (EPS) -3.07
EBITDA -96.23
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 21.18
Operating Expense 116.09
Net Profit -86.42
Net Profit Margin (%) -408.02
Earnings Per Share (EPS) -2.66
EBITDA -82.97
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 75.55
Operating Expense 493.13
Net Profit -388.11
Net Profit Margin (%) -513.71
Earnings Per Share (EPS) -11.96
EBITDA -374.32
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 238.78
Operating Expense 472.24
Net Profit -222.58
Net Profit Margin (%) -93.21
Earnings Per Share (EPS) -7.82
EBITDA -203.18
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 137.25
Operating Expense 347.49
Net Profit -203.40
Net Profit Margin (%) -148.19
Earnings Per Share (EPS) -7.73
EBITDA -179.91
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 252.96
Operating Expense 409.51
Net Profit -151.14
Net Profit Margin (%) -59.74
Earnings Per Share (EPS) -5.77
EBITDA -129.57
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 76.82
Operating Expense 398.98
Net Profit -312.40
Net Profit Margin (%) -406.66
Earnings Per Share (EPS) -11.92
EBITDA -300.24
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.12
EBITDA Margin -493.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -85.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 3.85
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.11
EBITDA Margin -495.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin -85.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share -7.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -131.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share -6.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -51.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share -0.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin -390.90
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 155.32
Total Assets 515.04
Total Liabilities 515.04
Total Equity 125.75
Share Outstanding 324521588
Price to Book Ratio 96.09
Return on Assets (%) -75.18
Return on Capital (%) -224.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 111.57
Total Assets 830.12
Total Liabilities 830.12
Total Equity 512.77
Share Outstanding 324521588
Price to Book Ratio 11.36
Return on Assets (%) -26.81
Return on Capital (%) -43.4
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 155.06
Total Assets 486.33
Total Liabilities 486.33
Total Equity 124.85
Share Outstanding 324521588
Price to Book Ratio 96.09
Return on Assets (%) -79.80
Return on Capital (%) -225.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 111.57
Total Assets 830.12
Total Liabilities 830.12
Total Equity 512.77
Share Outstanding 324521588
Price to Book Ratio 11.36
Return on Assets (%) -26.81
Return on Capital (%) -43.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.22
Total Assets 280.08
Total Liabilities 280.08
Total Equity 31.22
Share Outstanding 271878966
Price to Book Ratio -39.74
Return on Assets (%) -72.61
Return on Capital (%) -191.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.31
Total Assets 229.68
Total Liabilities 229.68
Total Equity -168.25
Share Outstanding 262047506
Price to Book Ratio -22.07
Return on Assets (%) -65.80
Return on Capital (%) -242.62
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 272.56
Total Liabilities 272.56
Total Equity -18.63
Share Outstanding 262047506
Price to Book Ratio -135.92
Return on Assets (%) -114.61
Return on Capital (%) -654.39
Particulars MAR 2024 (Values in Cr)
Net Income -386.83
Cash from Operations -425.07
Cash from Investing 391.52
Cash from Financing 42.40
Net change in Cash 4.74
Free Cash Flow -398.56
Particulars MAR 2023 (Values in Cr)
Net Income -222.58
Cash from Operations -74.48
Cash from Investing -548.27
Cash from Financing 616.75
Net change in Cash -0.64
Free Cash Flow -59.09
Particulars MAR 2024 (Values in Cr)
Net Income -388.10
Cash from Operations -425.31
Cash from Investing 391.11
Cash from Financing 42.79
Net change in Cash 4.47
Free Cash Flow -398.80
Particulars MAR 2023 (Values in Cr)
Net Income -222.58
Cash from Operations -74.48
Cash from Investing -548.27
Cash from Financing 616.75
Net change in Cash -0.64
Free Cash Flow -59.09
Particulars MAR 2022 (Values in Cr)
Net Income -203.39
Cash from Operations -212.77
Cash from Investing -29.16
Cash from Financing 229.32
Net change in Cash -8.07
Free Cash Flow -180.09
Particulars MAR 2021 (Values in Cr)
Net Income -151.13
Cash from Operations -150.26
Cash from Investing 1.56
Cash from Financing 159.28
Net change in Cash 8.95
Free Cash Flow -144.26
Particulars MAR 2020 (Values in Cr)
Net Income -312.40
Cash from Operations -200.94
Cash from Investing 155.34
Cash from Financing 55.46
Net change in Cash 0.00
Free Cash Flow -146.90
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 37.68 3.57 502.48 37.54 / 77.70
BLISS GVS PHARMA LTD 173.80 21.75 1.81 1830.67 92.25 / 175.80
CIPLA LTD 1446.35 25.30 4.11 116809.04 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.80 141.25 4.12 1197.25 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 57.02 11.14 502.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 751.60 45.72 7.29 2172.92 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6636.00 128.88 24.42 16590.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 173.80 22.66 1.78 1830.67 92.25 / 175.80

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 216.70
  • 26 Days 211.00
  • 10 Days 215.30
  • 50 Days 211.30
  • 12 Days 215.70
  • 100 Days 214.20
  • 20 Days 212.00
  • 200 Days 340.50
216.36
PIVOT
First Resistance 220.87
Second Resistance 226.50
Third Resistance 231.01
First Support 210.73
Second Support 206.22
Third Support 200.59
RSI 54.00
MACD 4.68
Commodity Channel Index (CCI) 60.76
ADX 7.30
Williams % R -31.56

Over 1 Month

down

4.80

Over 3 Months

down

-4.49

Over 6 Months

down

-3.20

Over 1 Year

down

-19.26

Over 3 Years

down

-8.31

Over 5 Years

down

5.70

SUN PHARMA ADV.RES.CO.LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SUN PHARMA ADV.RES.CO.LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
-37.5
Promoter Holdings
65.67
FII
2.14
DII
0.22
Promoter Shares(Pledge Percentage)
69.46
Name Category Shares Shares%
Shanghvi Finance Private Limited Shareholding of Promoter and Promoter Group 1.37211787E8 42.28
Dilip Shantilal Shanghvi Shareholding of Promoter and Promoter Group 6.181066E7 19.05
Sun Pharmaceutical Industries Key Employees Benefit Trust Public Shareholding 1.0317377E7 3.18
Jhunjhunwala Rekha Rakesh Public Shareholding 6292134.0 1.94
Lakshdeep Investments & Finance (p) Ltd. Public Shareholding 6033835.0 1.86
Aditya Medisales Limited Shareholding of Promoter and Promoter Group 4888126.0 1.51
Raksha S.valia Shareholding of Promoter and Promoter Group 4145231.0 1.28
Vijay Mohanlal Parekh Public Shareholding 3661304.0 1.13
Paresh Mohanlal Parekh Public Shareholding 3646837.0 1.12
Enam Securities Private Limited Public Shareholding 3370786.0 1.04
Sudhir Valia Shareholding of Promoter and Promoter Group 1833951.0 0.57
Unimed Investments Limited Shareholding of Promoter and Promoter Group 1267963.0 0.39
Vibha Dilip Shanghvi Shareholding of Promoter and Promoter Group 1063236.0 0.33
Vidhi Dilip Shanghvi Shareholding of Promoter and Promoter Group 344081.0 0.11
Aalok Dilip Shanghvi Shareholding of Promoter and Promoter Group 350162.0 0.11
Shanghvi Family & Friends Benefit Trust (kumud S. Shanghvi And Dilip S. Shanghvi) Shareholding of Promoter and Promoter Group 154922.0 0.05
Kumud S. Shanghvi Shareholding of Promoter and Promoter Group 38795.0 0.01
Gujarat Sun Pharmaceutical Industries Pvt Ltd Shareholding of Promoter and Promoter Group 1751.0 0.0
Sanghvi Properties Private Limited Shareholding of Promoter and Promoter Group 1887.0 0.0
Flamboyawer Finance Private Limited Shareholding of Promoter and Promoter Group 2543.0 0.0

SUN PHARMA ADV.RES.CO.LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SUN PHARMA ADV.RES.CO.LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUN PHARMA ADV.RES.CO.LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field

The share price of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 211.97 and for BSE is ₹ 212.05.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

Answer Field

The market cap of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 68,78.88 Cr. and for BSE is ₹ 68,81.48 Cr. as of now.

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

Answer Field

The 52 Week High and Low of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 472.80 and ₹ 189.75 and for BSE is ₹ 474.00 and ₹ 189.45.

How to Buy Sun Pharma Advanced Research Company Ltd share?

Answer Field

You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sun Pharma Advanced Research Company Ltd?

Answer Field

The 1 year returns on the stock has been -19.26%.

What is the Current Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field

Sun Pharma Advanced Research Company Ltd share price is for NSE ₹ 211.97 & for BSE ₹ 212.05 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd Share?

Answer Field

The market cap of Sun Pharma Advanced Research Company Ltd for NSE ₹ 68,78.88 & for BSE ₹ 68,81.48 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Sun Pharma Advanced Research Company Ltd share is -16.75.

What is the PB ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Sun Pharma Advanced Research Company Ltd share is 3.84.

How to Buy Sun Pharma Advanced Research Company Ltd Share?

Answer Field

You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sun Pharma Advanced Research Company Ltd Share on Bajaj Broking App?

Answer Field

To buy Sun Pharma Advanced Research Company Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sun Pharma Advanced Research Company Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader